In this workshop participants receive a theoretical background of Transcranial Magnetic Stimulation to treat Major Depression in clinical practice. It also presents emerging evidence as a therapy and protocols to treat OCD, as well as optimized benefits when combined with Psychotherapy and Sleep Hygiene Maintenance. Participants will receive an overview of TMS intake and safe delivery protocols. The prediction of treatment outcomes and QEEG markers of response and non-response to TMS will also be presented. The presenters will also introduce the new technique of Neuro-Cardiac Guided TMS (NCG-TMS), a state-of-the-art technique to accurately locate the DLPFC in stimulation.
This course will also present comparable neuromodulation techniques such as tDCS. The workshop is also suited to professionals with limited experience in neuromodulation and is supervised by globally recognised scientists and practitioners experienced in the neuromodulation research and clinical application.
This workshop is suited to Psychiatrists, to learn about TMS treatment prescription and mapping sessions, and is also suitable for TMS treatment provided by health care professionals, nurses or allied health professionals seeking to provide TMS treatment.
Dr Trevor Brown
Senior Neuroscientist, neuroCare Group Australia
Dr Martijn Arns
Founder & Research Director, Brainclinics (Netherlands)
Dr Mark Ryan
Psychiatrist & Clinical Director, neuroCare Australia
Joris van Neijenhof, Msc
Senior Clinician & Neuropsychologist, neuroCare Netherlands
*For professionals intending to administer TMS, an additional hands-on training workshop will be arranged on-site with neuroCare Group in Australia, Germany and The Netherlands, when travel and gathering restrictions are eased. Further details to be announced after the online course.
If you have any questions related to TMS technologies and/or further supervision, please write to